Skip to Main Content

Paper Details

A Randomized, Double-Blind, Placebo-Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss.
71
2019
Gelesis100, Patients, Weight, glucose, obesity, overweight, patients, prediabetes, type 2 diabetes
Author NameAffiliation
Lee M Kaplanand Nutrition Institute and Gastrointestinal Unit, Massachusetts General Hospital
Christopher D StillCenter for Nutrition and Weight, Geisinger Obesity Institute
  • 1 - 2

Datasets

Release 1.2